Erratum: TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
Journal of Hematology & Oncology volume 8, Article number: 101 (2015)
It has been brought to our attention that in Fig. two of the article , the immunoblots in the middle panel were incorrectly labeled as TREM2 instead of TMEM140. The correct figure is included below (Fig. 1), in which the immunoblots in the middle panel are labeled as TMEM140. This labeling correction does not affect the results or interpretation of the results. We apologize for this error.
Li B, Huang MZ, Wang XQ, Tao BB, Zhong J, Wang XH, et al. TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion. J Hematol Oncol. 2015;8(1):89. doi:10.1186/s13045-015-0187-4.
Bin Li and Ming-Zhu Huang contributed equally to this work.
The online version of the original article can be found under doi:10.1186/s13045-015-0187-4.
About this article
Cite this article
Li, B., Huang, MZ., Wang, XQ. et al. Erratum: TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion. J Hematol Oncol 8, 101 (2015). https://doi.org/10.1186/s13045-015-0199-0